2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works

Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · see citing works

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451 · see citing works

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161 · see citing works

Epigenetic Reprogramming in Mammalian Development

Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA

He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776 · see citing works

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

Ito, S., D’Alessio, A. C., Taranova, O., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,542 · see citing works

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works

Recurring mutations found by sequencing an acute myeloid leukemia genome

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works

IDH mutation impairs histone demethylation and results in a block to cell differentiation

Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works

Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,932 · see citing works

RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931 · see citing works

Chromatin modification and epigenetic reprogramming in mammalian development

Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900 · see citing works

Methylation-Induced Repression— Belts, Braces, and Chromatin

Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827 · see citing works

TNF-α Induces Two Distinct Caspase-8 Activation Pathways

Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,352 · see citing works

Glioma-Derived Mutations in <i>IDH1</i> Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119 · see citing works

Target identification using drug affinity responsive target stability (DARTS)

Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,113 · see citing works

Analysis of the IDH1 codon 132 mutation in brain tumors

Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036 · see citing works

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027 · see citing works

<i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023 · see citing works

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942 · see citing works

Frequent Mutation of Isocitrate Dehydrogenase<i>(IDH)1</i>and<i>IDH2</i>in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728 · see citing works

Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway

He, S., Liang, Y., Shao, F., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116302108 · Cited by 725 · see citing works

( <i>R</i> )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works

The metabolite alpha-ketoglutarate extends lifespan by inhibiting the ATP synthase and TOR

Chin, R., Fu, X., Pai, M. Y., Vergnes, L., Hwang, H., Deng, G., Diep, S., Lomenick, B., Meli, V., Monsalve, G. C., et al. (2014) · Nature · doi:10.1038/nature13264 · Cited by 570 · see citing works

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

Pansuriya, T. C., van Eijk, R., d'Adamo, P., van Ruler, M. A. J. H., Kuijjer, M. L., Oosting, J., Cleton-Jansen, A.-M., van Oosterwijk, J. G., Verbeke, S. L. J., Meijer, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.1004 · Cited by 559 · see citing works

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513 · see citing works

Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics

Koo, G.-B., Morgan, M. J., Lee, D., Kim, W.-J., Yoon, J.-H., Koo, J. S., Kim, S. H., Kim, S., Son, M. K., Hong, S. S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.56 · Cited by 489 · see citing works

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

Abbas, S., Lugthart, S., Kavelaars, F. G., Schelen, A. M., Koenders, J. E., Zeilemaker, A., van Putten, W. J. L., Rijneveld, A. W., Löwenberg, B., & Valk, P. J. M. (2010) · Blood · doi:10.1182/blood-2009-11-250878 · Cited by 394 · see citing works

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice

Sequist, L. V., Heist, R. S., Shaw, A. T., Fidias, P., Rosovsky, R., Temel, J. S., Lennes, I. T., Digumarthy, S., Waltman, B. A., Bast, E., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr489 · Cited by 370 · see citing works

IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors

Bleeker, F. E., Lamba, S., Leenstra, S., Troost, D., Hulsebos, T. J. M., Vandertop, W. P., Frattini, M., Molinari, F., Knowles, M. A., Cerrato, A., et al. (2009) · Human Mutation · doi:10.1002/humu.20937 · Cited by 365 · see citing works

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

Kang, M. R., Kim, M. S., Oh, J. E., Kim, Y. R., Song, S. Y., Seo, S. I., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24379 · Cited by 312 · see citing works

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Sasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes &amp; Development · doi:10.1101/gad.198200.112 · Cited by 296 · see citing works

Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA

Fatemi, M., Hermann, A., Gowher, H., & Jeltsch, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03198.x · Cited by 285 · see citing works

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death

Moriwaki, K., Bertin, J., Gough, P. J., Orlowski, G. M., & Chan, F. K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.16 · Cited by 244 · see citing works

2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling

Fu, X., Chin, R., Vergnes, L., Hwang, H., Deng, G., Xing, Y., Pai, M. Y., Li, S., Ta, L. H., Fazlollahi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.009 · Cited by 230 · see citing works

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells

Höckendorf, U., Yabal, M., Herold, T., Munkhbaatar, E., Rott, S., Jilg, S., Kauschinger, J., Magnani, G., Reisinger, F., Heuser, M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.002 · Cited by 197 · see citing works

Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2

Inoue, S., Li, W. Y., Tseng, A., Beerman, I., Elia, A., Bendall, S. C., Lemonnier, F., Kron, K. J., Cescon, D. W., Hao, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.018 · Cited by 194 · see citing works

Necroptosis: an alternative cell death program defending against cancer

Chen, D., Yu, J., & Zhang, L. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.003 · Cited by 182 · see citing works

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma

Cerhan, J. R., Ansell, S. M., Fredericksen, Z. S., Kay, N. E., Liebow, M., Call, T. G., Doǧan, A., Cunningham, J. M., Wang, A. H., Liu‐Mares, W., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088682 · Cited by 162 · see citing works

Ppm1b negatively regulates necroptosis through dephosphorylating Rip3

Chen, W., Wu, J., Li, L., Zhang, Z., Ren, J., Liang, Y., Chen, F., Yang, C., Zhou, Z., Sean Su, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3120 · Cited by 161 · see citing works

Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenases

Haselbeck, R. J., & McAlister-Henn, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50315-5 · Cited by 160 · see citing works

Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase

Aghajan, M., Jonai, N., Flick, K. M., Fu, F., Luo, M., Cai, X., Ouni, I., Pierce, N. W., Tang, X., Lomenick, B., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1645 · Cited by 138 · see citing works

IDH1andIDH2Mutations in Gliomas

Carli, E. D., Wang, X.-W., & Puget, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090593 · Cited by 134 · see citing works

Isocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas

Gaal, J., Burnichon, N., Korpershoek, E., Roncelin, I., Bertherat, J. Y., Plouin, P., de Krijger, R. R., Gimenez‐Roqueplo, A., & Dinjens, W. N. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2170 · Cited by 126 · see citing works

Microarray analysis of promoter methylation in lung cancers

Fukasawa, M., Kimura, M., Morita, S., Matsubara, K., Yamanaka, S., Endo, C., Sakurada, A., Sato, M., Kondo, T., Horii, A., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-005-0355-4 · Cited by 106 · see citing works

Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1

Liu, P., Xu, B., Shen, W., Zhu, H., Wu, W., Fu, Y., Chen, H., Dong, H., Zhu, Y., Miao, K., et al. (2011) · Leukemia · doi:10.1038/leu.2011.357 · Cited by 104 · see citing works

Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase

Pradhan, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.22.4666 · Cited by 99 · see citing works

Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes

Zhang, D., Zheng, M., Zhao, J., Li, Y.-Y., Huang, Z., Li, Z., & Han, J. (2011) · Cell Research · doi:10.1038/cr.2011.3 · Cited by 60 · see citing works

Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells

Yang, X., Lin, Z., Zhao, N., Zhou, L., Liu, F., Cichacz, Z. A., Zhang, L., Zhan, Q., & Zhao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100127 · Cited by 43 · see citing works

Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages

Rangel-Salazar, R., Lindholm, M., Aguilar-Salinas, C. A., Alvarado‐Caudillo, Y., Døssing, K. B. V., Esteller, M., Labourier, E., Lund, G., Nielsen, F. C., Rodríguez‐Ríos, D., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-582 · Cited by 41 · see citing works

Necroptosis and tumor progression

Yan, J., Wan, P., Choksi, S., & Liu, Z.-G. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.003 · Cited by 449 · see citing works

Coupling Krebs cycle metabolites to signalling in immunity and cancer

Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works

Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates

Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.005 · Cited by 242 · see citing works

The double-edged functions of necroptosis

Ye, K., Chen, Z., & Xu, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05691-6 · Cited by 220 · see citing works

2-Hydroxyglutarate in Cancer Cells

Ježek, P. (2020) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130 · see citing works

Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study

Cao, Y., Xie, L.-L., Shi, F., Tang, M., Li, Y.-S., Hu, J., Zhao, L., Zhao, L.-Q., Yu, X., Luo, X.-J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00376-4 · Cited by 115 · see citing works

Current translational potential and underlying molecular mechanisms of necroptosis

Molnár, T., Mázló, A., Tslaf, V., Szöllősi, A. G., Emri, G., & Koncz, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2094-z · Cited by 107 · see citing works

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression

He, R., Liu, Y., Fu, W., He, X., Liu, S., Xiao, D., & Tao, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02172-y · Cited by 99 · see citing works

Recent advances of IDH1 mutant inhibitor in cancer therapy

Tian, W., Zhang, W., Wang, Y., Jin, R., Wang, Y., Guo, H., Tang, Y., & Yao, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.982424 · Cited by 88 · see citing works

Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis

Liao, M., Chen, R., Yang, Y., He, H., Xu, L., Jiang, Y., Guo, Z., He, W., Jiang, H., & Wang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.015 · Cited by 71 · see citing works

Epigenetic Silencing of RIPK3 in Hepatocytes Prevents MLKL-mediated Necroptosis From Contributing to Liver Pathologies

Preston, S., Stutz, M. D., Allison, C. C., Nachbur, U., Gouil, Q. A., Tran, B. M., Duvivier, V., Arandjelovic, P., Cooney, J. P., Mackiewicz, L., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.040 · Cited by 68 · see citing works

Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities

Liu, S., Cadoux-Hudson, T. A. D., & Schofield, C. J. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.06.012 · Cited by 70 · see citing works

Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma

Tan, Y., Sementino, E., Cheung, M., Peri, S., Menges, C. W., Kukuyan, A.-M., Zhang, T., Khazak, V., Fox, L. A., Ross, E. A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3683 · Cited by 63 · see citing works

Recent advances in cancer metabolism: a technological perspective

Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 63 · see citing works

RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence

Lin, C., Mabe, N. W., Lin, Y.-T., Yang, W., Tang, X., Hong, L. T., Sun, T., Force, J. M., Marks, J. R., Yao, T., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0499-y · Cited by 58 · see citing works

EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter

Shi, F., Zhou, M., Li, S., Du, Q., Li, Y., Xie, L., Liu, X., Tang, M., Luo, X., Fan, J., et al. (2019) · Theranostics · doi:10.7150/thno.30941 · Cited by 58 · see citing works

Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases

Yang, G., Xia, Y., & Ren, W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1703-2 · Cited by 55 · see citing works

The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy

Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57 · see citing works

Metabolomics and the Multi-Omics View of Cancer

Wishart, D. S. (2022) · Metabolites · doi:10.3390/metabo12020154 · Cited by 51 · see citing works

A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma

Jiang, X., Deng, W.-Z., Tao, S., Tang, Z., Chen, Y.-H., Tian, M.-X., Wang, T., Tao, C., Li, Y.-Z., Fang, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00504-0 · Cited by 50 · see citing works

Inhibition of HSP90α protects cultured neurons from oxygen‐glucose deprivation induced necroptosis by decreasing RIP3 expression

Wang, Z., Guo, L., Wang, Y., Zhou, H., Wang, S., Chen, D., Huang, J., & Xiong, K. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26294 · Cited by 50 · see citing works

RSK3 mediates necroptosis by regulating phosphorylation of RIP3 in rat retinal ganglion cells

Wang, M., Wan, H., Wang, S., Liao, L., Huang, Y., Guo, L., Liu, F., Shang, L., Huang, J., Ji, D., et al. (2020) · Journal of Anatomy · doi:10.1111/joa.13185 · Cited by 42 · see citing works

Insights into DNMT1 and programmed cell death in diseases

Yan, L., Geng, Q., Cao, Z., Liu, B., Li, L., Lu, P., Lin, L., Wei, L., Tan, Y., He, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115753 · Cited by 41 · see citing works

TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma

Podder, B., Guttà, C., Rožanc, J., Gerlach, E., Feoktistova, M., Panayotova‐Dimitrova, D., Alexopoulos, L. G., Leverkus, M., & Rehm, M. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0315-8 · Cited by 40 · see citing works

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer

Liu, Y., Xu, W., Li, M., Yang, Y., Sun, D., Chen, L., Li, H., & Chen, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.019 · Cited by 35 · see citing works

Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines

Koch, A., Jeiler, B., Roedig, J., van Wijk, S. J. L., Dolgikh, N., & Fulda, S. (2021) · Neoplasia · doi:10.1016/j.neo.2021.03.003 · Cited by 34 · see citing works

Pin1 Promotes Regulated Necrosis Induced by Glutamate in Rat Retinal Neurons via CAST/Calpain2 Pathway

Wang, S., Liao, L., Wang, M., Zhou, H., Huang, Y., Wang, Z., Chen, D., Ji, D., Xia, X., Wang, Y., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00425 · Cited by 31 · see citing works

Oncometabolite L‐2‐hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma

Wang, H., Wang, L., Zheng, Q., Lu, Z., Chen, Y., Shen, D., Xue, D., Jiang, M., Ding, L., Zhang, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33435 · Cited by 31 · see citing works

IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma

Chen, X., Liu, J., Li, Y., Zeng, Y., Wang, F., Cheng, Z., Duan, H., Pan, G., Yang, S., Chen, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42545-3 · Cited by 30 · see citing works

Attenuated Epigenetic Suppression of Muscle Stem Cell Necroptosis Is Required for Efficient Regeneration of Dystrophic Muscles

Sreenivasan, K., Ianni, A., Künne, C., Strilić, B., Günther, S., Perdiguero, E., Krüger, M., Spuler, S., Offermanns, S., Arco, P. G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107652 · Cited by 26 · see citing works

Cell death and cancer: Metabolic interconnections

Dalseno, D., Gajic, N., Flanagan, L., & Tait, S. W. G. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115804 · Cited by 26 · see citing works

Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist

Boccellato, C., Kolbe, E., Peters, N., Jurić, V., Fullstone, G., Verreault, M., Idbaïh, A., Lamfers, M. L. M., Murphy, B. M., & Rehm, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03927-x · Cited by 25 · see citing works

RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping

Vergara, G. A., Eugenio, G. C., Malheiros, S. M. F., Victor, E. D. S., & Weinlich, R. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03473-0 · Cited by 24 · see citing works

Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases

Gupta, R. V., Kumari, S., Tripathi, R. S., Ambasta, R. K., & Kumar, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101855 · Cited by 26 · see citing works

Harnessing luciferase chemistry in regulated cell death modalities and autophagy: overview and perspectives

Hosseinkhani, S., Amandadi, M., Ghanavatian, P., Zarein, F., Ataei, F., Nikkhah, M., & Vandenabeele, P. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00743j · Cited by 24 · see citing works

Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis

Wu, X., Lu, Y., & Qin, X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114690 · Cited by 23 · see citing works

Programmed cell death in triple-negative breast cancer

Liu, Y., He, J., Chen, J., Chen, T., Li, W., Yang, Z., & Zeng, F. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00789-5 · Cited by 22 · see citing works

Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases

Rucker, A. J., & Chan, F. K.-M. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.12.004 · Cited by 20 · see citing works

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma

Huang, J., Xu, Z., Teh, B. M., Zhou, C., Yuan, Z., Shi, Y., & Shen, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24480 · Cited by 18 · see citing works

An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors

Verdura, S., Cuyàs, E., Lozano‐Sánchez, J., Bastidas-Velez, C., Llorach-Parés, L., Fernández‐Arroyo, S., Hernández‐Aguilera, A., Joven, J., Nonell‐Canals, A., Bosch‐Barrera, J., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy159 · Cited by 17 · see citing works

Identification of cuproptosis‐related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma

Huang, J., Xu, Z., Yuan, Z., Cheng, L.-X., Zhou, C., & Shen, Y. (2022) · Journal of clinical laboratory analysis (Print) · doi:10.1002/jcla.24638 · Cited by 13 · see citing works

Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers

Awasthi, P., Dwivedi, M., Kumar, D., & Hasan, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121261 · Cited by 17 · see citing works

IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5

Yan, B., Hu, Y., Ma, T., & Wang, Y. (2018) · Open Biology · doi:10.1098/rsob.180086 · Cited by 16 · see citing works

Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer

Hao, J., Huang, Z., Zhang, S., Song, K., Wang, J., Gao, C., Fang, Z., & Zhang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107437 · Cited by 15 · see citing works

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma

Guo, Y., Li, Y., Li, J., Tao, W., & Dong, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.629521 · Cited by 15 · see citing works

Genomic locus proteomic screening identifies the NF-κB signaling pathway components NFκB1 and IKBKG as transcriptional regulators of Ripk3 in endothelial cells

Gao, S., Menendez, M. T., Kuryłowicz, K., & Griffin, C. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253519 · Cited by 13 · see citing works

Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma

Shi, F., Li, S., Zhou, M., Lv, C., Li, Y., Luo, C., Liu, N., Lu, J., Tang, M., Luo, X., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29634 · Cited by 12 · see citing works

Forms of Non-Apoptotic Cell Death and Their Role in Gliomas—Presentation of the Current State of Knowledge

Nafe, R., & Hattingen, E. (2024) · Biomedicines · doi:10.3390/biomedicines12071546 · Cited by 11 · see citing works

Necroptosis in immunity, tissue homeostasis, and cancer

Yin, J., Yu, Y., Huang, X., & Chan, F. K.-M. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102455 · Cited by 11 · see citing works

Cell Death and Disease

Xu, K. (2022) · Biochemistry · doi:10.5772/intechopen.104360 · Cited by 9 · see citing works

Glutaminolysis and peripheral CD4+ T cell differentiation: from mechanism to intervention strategy

Liu, T., Ren, S., Sun, C., Zhao, P., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221530 · Cited by 7 · see citing works

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM

Song, C., Zhu, L., Gu, J., Wang, T., Shi, L., Li, C., Chen, L., Xie, S., & Lu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1024208 · Cited by 7 · see citing works

Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation

Xu, K., Zhang, C., Li, Y., Xi, X., Zheng, L., Meng, M., Liu, T., Zhao, Y., & Li, W. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.09.57 · Cited by 7 · see citing works

Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma

Duan, X., Du, H., Yuan, M., Liu, L., Liu, R., & Shi, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12030 · Cited by 6 · see citing works

A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing

Guo, K., Duan, X., Zhao, J., Sun, B., Liu, X., & Zhao, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.984712 · Cited by 4 · see citing works

Epi-Regulation of Cell Death in Cancer

Beato, A., Torre, L. D., Capone, V., Carannante, D., Favale, G., Verrilli, G., Altucci, L., & Carafa, V. (2023) · Biochemistry · doi:10.5772/intechopen.108919 · Cited by 4 · see citing works

A genetically encoded fluorescent sensor enables sensitive and specific detection of IDH mutant associated oncometabolite D-2-hydroxyglutarate

Choate, K. A., Konickson, W., Moreno, Z., Brill, O. S., Cromell, B. C., Detienne, B. M., Jennings, M. J., Mann, P. B., Winn, R. J., Kamson, D. O., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13877-8 · Cited by 4 · see citing works

Regulated necrosis at the crossroads of liver inflammation and cancer development

Vucur, M., Kondylis, V., Brož, P., & Luedde, T. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01147-8 · Cited by 3 · see citing works

MMP14‐Dependent Activation of TGF‐β Signaling Enhances Malignancies via Promoting Necroptosis in Glioblastoma

Zhou, H., Wu, W., Cao, Y., Zhang, B., Zhou, M., Wang, Y., Wang, M., & Wang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501932r · Cited by 3 · see citing works

Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications

Fang, Y., Wang, X., Luo, K., Dakal, T. C., Bai, H., Xu, C., & Zhang, G. (2026) · MedComm · doi:10.1002/mco2.70732 · Cited by 4 · see citing works

Danger or Salvation? The Role of DAMPs in Cancer Therapy

Vedunova, A. A., Guryev, E. L., Gudkov, S. V., Mishchenko, T. A., & Vedunova, M. V. (2026) · Cancers · doi:10.3390/cancers18091442 · Cited by 3 · see citing works

Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer

Duan, X., Hou, R., Huang, Y., Wang, C., Liu, L., Du, H., & Shi, J. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101983 · Cited by 3 · see citing works

Discovery of Aloperine as a Potential Antineoplastic Agent for Cholangiocarcinoma Harboring Mutant IDH1

Wu, X., Li, Y., Han, C., Li, S.-F., & Qin, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179226 · Cited by 3 · see citing works

The necroptosis-related lncRNA ENSG00000253385.1 promotes the progression of esophageal squamous cell carcinoma by targeting the miR-16-2-3p/VDAC1 axis

Duan, X., Shi, J., Hou, R., Huang, Y., Wang, C., & Du, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-85646-3 · Cited by 3 · see citing works

Development of a new in vitro assay system for evaluating the effects of chemicals on DNA methylation

Ideta-Otsuka, M., Miyai, M., Yamamoto, N., Tsuchimoto, A., Tamura, H., Tanemura, K., Shibutani, M., & Igarashi, K. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.83 · Cited by 1 · see citing works

A patent review of IDH1 inhibitors (2018-present)

Liang, Q., Wen, F., Wang, P., Jiang, Y., Geng, Y., & Zha, X. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2500959 · Cited by 1 · see citing works

Non-canonical regulated cell death and epigenetic mechanisms in the nervous system

Merighi, A., Castagna, C., Sbriz, M., & Lossi, L. (2026) · Frontiers in Cell Death · doi:10.3389/fceld.2026.1793102 · Cited by 1 · see citing works

Maffucci Syndrome Complicated by Giant Chondrosarcoma in the Left Ankle with an IDH1 R132C Mutation: Case ReportPreprint

Lv, H., Jiang, H., Zhang, M., Luo, H., Hong, Z., Yang, H., Xu, W., Shen, B., & Zhu, R.-T. (2021) · Research Square · doi:10.21203/rs.3.rs-771590/v1 · Cited by 1 · see citing works

Pengaruh Penerapan Keselamatan dan Kesehatan Kerja (K3) dan Kondisi Kelayakan Bengkel Terhadap Prestasi Belajar Peserta Didik pada Bengkel Pemesinan SMK Negeri 3 Boyolangu Kabupaten Tulungagung

Wibowo, A. (2014) · SKRIPSI Jurusan Teknik Mesin - Fakultas Teknik UM

Modulação gênica de RIPK3 e MLKL e seu impacto na sensibilidade a morte por necroptose

Zanetti, L. (2021) · doi:10.31744/pg2021.107972

Biochemical and Genetic Markers in Neurological Trauma and Tumors: Review Article

Ashraf, O., Saleem, T. H., Elsadek, B., Hamdan, A. R. K., & Hassan, M. H. (2022) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2022/v11i230260

Data from Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma

Tan, Y., Sementino, E., Cheung, M., Peri, S., Menges, C. W., Kukuyan, A.-M., Zhang, T., Khazak, V., Fox, L. A., Ross, E. A., et al. (2023) · doi:10.1158/1078-0432.c.6528651.v1

Targeted mutation-based therapy for intrahepatic cholangiocarcinoma

Yang, F., Qiu, Y., & Yi, B. (2023) · Hepatoma Research · doi:10.20517/2394-5079.2023.68

Unraveling the Interplay of D-2-HG in Glioblastoma Tumorigenesis via Integrated Machine Learning and Molecular Docking Analysis

Zou, Y., Yu, X., Li, Q., Wu, Q., & Zhuang, J. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl47692

Échapper à la mort cellulaire dans le cancer : mitophagie et régulation de la mort indépendante des caspases

Villa, E. (2017) · theses.fr (ABES) · doi:10.70675/f0d1579dzdd47z4ac8z82abz4e3b85a0100b

Epigenetic regulation of non-apoptotic regulated cell death

El‐Sehrawy, A. A. M. A., Oriquat, G., Razyikova, L., Ne'matova, H., Ergashev, N., Ali, N. M., Bainsal, N., & Singh, R. (2026) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2026.151552

Regulated cell death in the nervous system: a framework for execution diversity and spatially restricted degeneration

Lossi, L., Sbriz, M., Castagna, C., & Merighi, A. (2026) · Frontiers in Cell Death · doi:10.3389/fceld.2026.1823132

Temozolomide resistance in glioblastoma: Multidimensional networks, core signaling hubs, and targeted therapeutic strategies

Qin, Y., Zhao, Y., Li, B., Zhu, K., Jiang, T., Li, N., & 姜同翠 (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120221

R-2-Hydroxyglutarate Induces RIPK1-Dependent Necroptosis via Inhibition of KDM2B in Myeloid MalignanciesPreprint

Zhu, S., Mei, C., Jiang, L., Yang, W., Luo, Y., Wang, L., Zhang, H., Lin, P., Xu, W., Zhou, X., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3696871

D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant–Induced MIR148A Promoter Methylation

Li, T., Cox, C. D., Ozer, B. H., Nguyen, N. T., Nguyen, H. N., Lai, T. J., Li, S., Liu, F., Kornblum, H. I., Liau, L. M., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0367 · Cited by 18 · see citing works

Epigenetic modulation of RIPK3 by transglutaminase 2-dependent serotonylation of H3K4me3 affects necroptosis

Vecchio, A., Colasuonno, F., Occhigrossi, L., Pitolli, C., Bellanca, V., Ciccarone, F., D’Eletto, M., Sano, F. D., Pagliarini, V., Sette, C., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05640-w · Cited by 9 · see citing works

2-hydroxyglutarate inhibits MyoD-mediated differentiation by preventing H3K9 demethylation

Schvartzman, J. M., Reuter, V. P., Koche, R. P., & Thompson, C. B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817662116 · Cited by 40 · see citing works

CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP

Moure, C. J., Diplas, B. H., Chen, L. H., Yang, R. R., Pirozzi, C. J., Wang, Z., Spasojević, I., Waitkus, M. S., He, Y., & Yan, H. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0309 · Cited by 28 · see citing works